Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Peptides, Lipopeptides Used to Fight Bacteria

By Biotechdaily staff writers
Posted on 26 Jan 2007
By combining major characteristics of two different types of tools used by the innate defense systems of organisms, a team of scientists has managed to devise a more powerful weapon, hoping that this will provide a basis for more innovative and effective antibiotics. More...


The first is a "magnetic” weapon--a natural antibiotic produced by all organisms. Because these antimicrobial peptides (AMPs) are positively charged, they are attracted to the bacteria's negatively charged surface similar to a magnet, where they can then exert their antibacterial effects. The second, "detergent-like” weapon, called a lipopeptide, is produced only by bacteria and fungi, which, due to a negative charge, target mainly fungi. This weapon contains a fatty acid chain that, similar to chains in soap that dissolve dirt and oils, breaks down the fatty membranes of the fungi.

In the study, published in the October 12, 2006, issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS), Prof. Yechiel Shai and Ph.D. students Arik Makovitzki and Dorit Avrahami from the biological chemistry department at the Weizmann Institute of Science (Rehovot, Israel) have effectively combined the properties of AMPs with lipopeptides, resulting in a synthetic lipopeptide that has both a positive charge and the soap-like ability to dissolve oils.

By changing the length of the fatty acid chains and the sequence of positively charged amino acids, the investigators were able to create a range of weapons. Some are active against both bacteria and fungi, whereas others target just one or the other. Furthermore, they managed to design these new synthetic peptides (protein fragments) to contain only four amino acids, as opposed to the 12-50 found in their natural forms.

These results will hopefully provide a whole new range of potential applications. The short length of the synthetic peptide makes it appealing for drug design as it would be both easier and economically less expensive to synthesize, less prone to resistance, and potentially engineered to target a large array of bacterial and fungal infections.



Related Links:
Weizmann Institute of Science

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.